Markus Isenmann is the Franchise Head of Immunology in Germany at Sanofi Genzyme, a position held since 2022. Previously, Markus served in various roles at Pfizer from 2015 to 2016, including Oncology Business Unit Lead for Poland and several positions focused on process optimization and portfolio management across Europe. Earlier, Markus worked as the Oncology Sub-Cluster Lead for Eastern Europe, managing the oncology P&L for multiple regions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices